Abstract
Our patient was a 28 year-old female with recurrent, drug-resistant ventricular arrhythmia, including non sustained ventricular tachycardia (nsVT) and ventricular ectopic beats (VEBs) (> 10.000/24 h).
Echocardiography revealed no structural heart disease. Given that the patient was symptomatic and the arrhythmia was resistant to drugs, she was referred to our center for radiofrequency catheter ablation (RFCA). Antiarrhythmic medication was discontinued > 5 half-lives before the procedure. Following the initial activation and pace mapping in the right ventricular outflow tract, the mapping/ablation catheter (Marinr MC 4-mm tip, Medtronic, Fridley, MN, USA) was introduced into the left ventricle using a transaortic approach. The origin of the arrhythmia was localized in the left ventricular outflow tract, approximately 1.5 cm below the left aortic cusp (Fig. 1) .
The mapping was supported by the electroanatomic system (LocaLisa, Medtronic) RF energy application (50 W/60°C) with a 4-mm tip ablation catheter, resulting in suppression of the arrhythmia. After 43 s of RF application, the catheter suddenly dislocated, likely due to respiratory movement, and was moved above the aortic valve and into the ostium of the left main (LM) artery. The RF application was terminated immediately and the catheter was withdrawn. The patient developed severe symptoms of acute coronary hypoperfusion and cardiac arrest in the mechanism of asystole.
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Immediate resuscitation resulted in the restoration of an idioventricular rhythm without sufficient hemodynamic response.
Echocardiography (in emergency) revealed important left-ventricle hypokinesis (antero-septal). With ongoing resuscitation, coronary angiography was performed, confirming acute occlusion of the LM artery. An electrode for intraventricular pacing was also inserted. In the first step, a direct stenting of the LM with a Cypher stent (3.5/8 mm; Cordis, Bridgewater, NJ, USA) was attempted. During stenting, a very strong contraction of the LM resulted in dislocation of the stent into the ostium of the LM. Stent thrombosis was observed. Treatment with abciximab (ReoPro, Eli Lilly, Indianapolis, IN, USA) was introduced, and the second stent (3.5/20 mm; CoCr stent, Skylor, Invatec, Roncadelle, Italy) was implanted from the LM to the left anterior descending, with TIMI 3 flow restoration. Hemodynamic heart function reappeared, with normal sinus rhythm. An intra-aortic balloon pump was inserted.
In the coronary care unit, the follow-up (FU) was complicated by pneumonia and heparin induced thrombocytopenia with the lowest platelet count at 32 K/mL.
A myocardial infarction was confirmed, with an increase of troponin I to a maximum of > 50.0 ng/ /mL. A control echocardiography revealed anteroseptal and apical hypokinesis with an ejection fraction of 45% on discharge.
In the second and third months after hospitalization, a control echocardiography was performed. The ejection fraction was calculated at 56%, with only slight periapical dyskinesia.
After six months, the first control 64-multislice computed tomography was performed. Normal aspects for LM were observed, without restenosis. The ejection fraction was 51%, and the left ventricular end-diastolic volume was 126 mL (Fig. 2) .
Otherwise, the patient was asymptomatic. At the one-year FU, a computed tomography scan yielded similar results to those observed at the sixmonth FU (Fig. 2B) . In the control ECG Holter, we identified no significant arrhythmias (VEBs 93/24 h, with no VT runs).
Currently, the patient is being treated with 25 mg metoprolol and 75 mg aspirin daily.
This case demonstrates a rare complication of RFCA [1, 2] . The mechanism of the initial injury to the LM artery remains unclear; it is possible that the cause of the occlusion was an acute LM dissection. It should be evaluated whether precise delineation of the coronary anatomy before the application would increase the safety of the procedure.
These procedures are useful and in fact, mandatory when treating arrhythmias originating from aortic cusps, but not from sites below the aortic valve [3] . In this case, the coronary catheter placed in the LM could mechanically prevent the ablation catheter from entering into the vessel. Electro--anatomic mapping does not prevent the dislocation of the ablation catheter. Thus, we recommend performing a coronary angiography (with the catheter left in the LM during RF application) not only in arrhythmias originating from the aortic cusps, but also for sub-valvular sites that are at risk of catheter dislocation.
Finally, little data exists regarding the long--term FU in patients with LM coronary artery stenting following an injury resulting from RF ablation.
Therefore, we intend to keep our patient under very close medical supervision for a long time. A B
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